Are stroke units cost effective? Evidence from a New Zealand stroke incidence and population-based study.
OBJECTIVE
Acute stroke units in hospitals are known to be more costly than standard care, but proponents claim that the health gains will justify the expense. Yet, despite widespread adoption of stroke units, the evidence on the cost effectiveness of stroke units has been mixed, due in part to differences in the pathway of care across hospitals. The purpose of this study is to compare costs and outcomes for patients admitted to a stroke unit with those admitted to a general ward.


METHODS
Data on 530 stroke sufferers from a large incidence study of stroke (the Auckland Regional Community Stroke Outcome Study) were used. Cost of health services, places of discharge were identified at one-, six- and 12 months poststroke and were linked with long-term cost and survival five-years poststroke. A decision analytical model was developed, including the relationship between waiting time for discharge and probability of admission to stroke unit. Cost effectiveness was determined using a willingness to pay threshold of NZ$20 000 (US$15 234).


RESULTS
Regression analysis suggested that there were no significant differences between patients admitted to a stroke unit and a general ward. The incremental cost-utility ratio for the first-year was NZ$42 813/quality-adjusted life year (US$32 610/quality-adjusted life year), but fell substantially to NZ$6747/quality-adjusted life year (US$5139/quality-adjusted life year) when lifetime costs and outcomes were considered. Probabilistic and one-way sensitivity analysis suggests that the results are robust to areas of uncertainty or delays in the pathway of care.


CONCLUSIONS
Stroke unit care was cost effective in Auckland, New Zealand.
National Institute for Stroke and Applied Neurosciences, School of Rehabilitation and Occupational Studies, School of Public Health and Psychosocial Studies, Auckland University of Technology, Auckland, New Zealand. braden.teao@aut.ac.nz
Braden J
BJ
Te Ao
Paul M
PM
Brown
Valery L
VL
Feigin
Craig S
CS
Anderson
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003362:Cost-Benefit Analysis; D005260:Female; D006757:Hospital Units / Q000191:economics*; D006801:Humans; D015994:Incidence; D007902:Length of Stay / Q000191:economics; D008017:Life Expectancy; D008297:Male; D008875:Middle Aged; D009520:New Zealand / Q000453:epidemiology; D011788:Quality of Life; D012008:Recurrence; D020521:Stroke / Q000191:economics / Q000401:mortality / Q000628:therapy*; D016896:Treatment Outcome; D055815:Young Adult